Lidocaine Hydrochloride Laboratoire Aguettant

Lidocaine Hydrochloride, the active ingredient in Lidocaine Hydrochloride Laboratoire Aguettant, is a local anesthetic presented as a sterile solution for epidural, infiltration, intravenous, and subcutaneous use. It provides local anesthesia for minor surgical or dental procedures, epidural analgesia during labor or surgery, intravenous antiarrhythmic therapy, and peripheral nerve block.

GNH USA supplies Lidocaine Hydrochloride Laboratoire Aguettant as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Lidocaine Hydrochloride is used to provide local anesthesia and analgesia across several clinical pathways.

- Minor surgical or dental procedures: provides rapid, reversible loss of sensation at the targeted site. - Epidural analgesia during labor or surgery: delivers continuous pain relief while preserving consciousness. - Intravenous antiarrhythmic therapy: stabilises cardiac rhythm in certain arrhythmias. - Peripheral nerve block: produces regional anesthesia for limb surgeries.

Adverse reactions to lidocaine may vary in frequency and severity.

Common Side Effects: - Burning or tingling at the injection site. - Light‑headedness or dizziness. - Nausea. - Metallic taste. - Mild hypotension. - Headache.

Serious or Rare Side Effects: - Anaphylactic reaction (severe allergy). - Cardiac arrhythmias, including ventricular tachycardia. - Central nervous system toxicity such as seizures or loss of consciousness. - Methemoglobinemia. - Persistent numbness or motor weakness. - Respiratory depression.

When using lidocaine, careful assessment and monitoring are essential.

- Patient assessment: evaluate cardiac history, liver function, and allergy status. - Dose calculation: base on patient weight, site of administration, and maximum recommended limits. - Monitoring: observe vital signs and neurologic status during epidural or intravenous use. - Contraindications: avoid in individuals with known lidocaine hypersensitivity. - Use with caution: patients with severe heart block, hepatic impairment, or electrolyte disturbances may be at higher risk. - Store at ambient temperature: keep in the original container, protect from light and moisture.

Lidocaine may interact with other medications, altering its safety profile.

Major Interactions (Avoid): - Class I antiarrhythmics (e.g., quinidine, procainamide): increase risk of lidocaine toxicity. - Strong CYP3A4 inhibitors (e.g., ketoconazole, erythromycin): raise plasma lidocaine concentrations. - Beta‑blockers (e.g., propranolol): potentiate cardiac depressant effects.

Moderate Interactions (Monitor Closely): - Class II antiarrhythmics (e.g., metoprolol): may enhance bradycardia. - Diuretics (e.g., furosemide): alter plasma protein binding, affecting free lidocaine levels. - General anesthetics (e.g., propofol, volatile agents): additive central nervous system depression.